Complete Filing Data
Oklo Inc. reported Stockholders Equity of $1.48 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Oklo Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income * | -$105.7M | -$73.6M | -$32.2M | $3.9M | -$1.1M |
| Operating Income Loss | -$139.3M | -$52.8M | -$18.6M | -$1.8M | -$1.2M |
| Nonoperating Income Expense | $29.1M | -$20.1M | -$13.5M | $7.2M | $125.5K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$110.2M | -$72.9M | -$32.2M | $5.4M | -$1.1M |
| Income Tax Expense Benefit | -$4.5M | $683.0K | $0.00 | $1.5M | $2.4K |
| Research And Development Expense | $58.9M | $26.7M | $9.8M | ||
| Operating Expenses | $139.3M | $52.8M | $18.6M | ||
| General And Administrative Expense | $80.4M | $26.1M | $8.9M | ||
| Comprehensive Income Net Of Tax | -$106.7M | -$71.4M | -$32.2M | ||
| Accrued Income Taxes Current | $1.2M | $2.4K | |||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -$1.0M | $2.2M | $0.00 | ||
| Deferred Income Tax Liabilities Net | $1.2M | $0.00 | $294.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$29.7M | -$24.7M | -$9.8M | -$10.0M | -$27.3M | -$24.0M | -$8.7M | -$4.5M | -$4.7M | $1.5M | $54.4K | -$388.2K | -$535.2K | $0.00 | -$1.0K | |
| Operating Income Loss | -$36.3M | -$28.0M | -$17.9M | -$12.3M | -$17.8M | -$7.4M | -$4.7M | -$3.4M | -$1.2M | -$402.6K | -$430.7K | -$529.1K | -$569.0K | -$1.0K | ||
| Nonoperating Income Expense | $7.1M | $3.8M | $3.7M | $2.5M | -$9.4M | -$16.7M | -$4.0M | -$1.1M | $5.4M | $2.4M | $577.2K | $140.9K | $33.8K | |||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$29.2M | -$24.3M | -$14.2M | -$9.7M | -$27.1M | -$24.0M | -$8.7M | -$4.5M | $4.2M | $2.0M | $146.5K | -$388.2K | -$535.2K | |||
| Income Tax Expense Benefit | $531.0K | $431.0K | -$4.4M | $225.0K | $164.0K | $0.00 | $0.00 | $1.2M | $1.1M | $534.6K | $92.1K | |||||
| Research And Development Expense | $14.9M | $11.5M | $7.8M | $5.1M | $10.7M | $3.7M | $1.7M | $1.8M | ||||||||
| Operating Expenses | $36.3M | $28.0M | $17.9M | $12.3M | $17.8M | $7.4M | $4.7M | $3.4M | ||||||||
| General And Administrative Expense | $21.4M | $16.5M | $10.0M | $7.2M | $7.1M | $3.7M | $3.0M | $1.5M | ||||||||
| Comprehensive Income Net Of Tax | -$27.5M | -$25.0M | -$10.4M | -$7.7M | -$26.9M | -$24.0M | -$8.7M | -$4.5M | ||||||||
| Accrued Income Taxes Current | $1.5M | $805.1K | $1.2M | $1.2M | $2.6M | $626.7K | $92.1K | $2.4K | ||||||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $2.3M | -$329.0K | -$561.0K | $2.3M | $418.0K | $0.00 | $0.00 | |||||||||
| Deferred Income Tax Liabilities Net | $1.0M | $1.0M | $1.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | $1.48B | $250.9M | -$34.4M | -$3.1M | -$13.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $788.4M | $97.1M | $9.9M | $9.7M | $3.3M |
| Retained Earnings Accumulated Deficit | -$240.8M | -$135.1M | -$61.5M | -$13.8M | -$13.2M |
| Liabilities Current | $25.5M | $5.3M | $3.2M | $1.5M | $310.4K |
| Liabilities And Stockholders Equity | $1.53B | $281.7M | $14.9M | $510.1M | $504.7M |
| Cash And Cash Equivalents At Carrying Value | $788.4M | $97.1M | $9.9M | $3.6M | $3.3M |
| Assets | $1.53B | $281.7M | $14.9M | $510.1M | $504.7M |
| Liabilities | $52.2M | $30.9M | $49.2M | $19.4M | $17.9M |
| Assets Current | $1.25B | $231.9M | $14.2M | $4.0M | $4.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $691.3M | $87.3M | $214.0K | $240.3K | $3.3M |
| Accrued Liabilities Current | $20.5M | $1.9M | $836.0K | $303.3K | $295.3K |
| Interest Earned On Marketable Securities Held In Trust Account | $22.2M | $7.3M | $117.7K | ||
| Unrealized Gain Loss On Investments | -$68.1K | $7.8K | |||
| Deferred Offering Costs Noncurrent | $17.5M | $17.5M | |||
| Assets Held In Trust Noncurrent | $506.1M | $500.1M | |||
| Deferred Legal Fees Noncurrent | $118.7K | $92.4K | |||
| Property Plant And Equipment Net | $42.3M | $1.2M | $578.0K | ||
| Prepaid Expense And Other Assets Current | $25.8M | $4.1M | $4.3M | ||
| Operating Lease Right Of Use Asset | $1.4M | $982.0K | $83.0K | ||
| Operating Lease Liability Current | $904.0K | $481.0K | $94.0K | ||
| Deferred Issuance Costs Included In Accounts Payable | $0.00 | $1.9M | $443.0K | ||
| Common Stock Value | $16.0K | $14.0K | $7.0K | ||
| Accounts Payable Current | $4.1M | $3.0M | $2.3M | ||
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | $0.00 | ||
| Other Assets Noncurrent | $12.3M | $140.0K | $25.0K | ||
| Right Of First Refusal Liability | $25.0M | $25.0M | $0.00 | ||
| Operating Lease Liability Noncurrent | $546.0K | $543.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $1.21B | $696.4M | $269.3M | $263.3M | $269.3M | -$57.3M | -$20.7M | -$12.2M | -$7.7M | -$13.4M | -$13.5M | -$13.6M | -$12.7M | $24.0K | $24.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $410.0M | $226.8M | $90.1M | $91.8M | $105.7M | $38.0M | $10.0M | $5.1M | $2.9M | $2.6M | $3.0M | $3.2M | $3.4M | $205.9K | $226.5K | ||
| Retained Earnings Accumulated Deficit | -$199.3M | -$169.6M | -$144.9M | -$124.8M | -$114.9M | -$14.8M | -$16.7M | -$14.8M | -$13.9M | -$13.4M | -$13.5M | -$13.6M | -$12.7M | -$1.0K | |||
| Liabilities Current | $13.8M | $7.6M | $5.7M | $4.8M | $4.9M | $4.6M | $2.4M | $1.6M | $3.3M | $947.7K | $628.3K | $473.7K | $109.3K | $898.0K | |||
| Liabilities And Stockholders Equity | $1.25B | $731.1M | $302.1M | $293.8M | $299.2M | $308.2M | $520.0M | $516.8M | $514.7M | $506.5M | $504.7M | $504.5M | $504.9M | $922.0K | |||
| Cash And Cash Equivalents At Carrying Value | $410.0M | $226.8M | $90.1M | $91.8M | $105.7M | $420.8K | $1.7M | $840.2K | $2.9M | $2.6M | $3.0M | $3.2M | $3.4M | $205.9K | |||
| Assets | $1.25B | $731.1M | $302.1M | $293.8M | $299.2M | $308.2M | $520.0M | $516.8M | $514.7M | $506.5M | $504.7M | $504.5M | $504.9M | $922.0K | |||
| Liabilities | $40.6M | $34.7M | $32.8M | $30.5M | $29.9M | $11.6M | $20.0M | $19.2M | $20.8M | $18.5M | $18.2M | $18.1M | $17.6M | ||||
| Assets Current | $931.8M | $542.7M | $204.9M | $234.8M | $239.2M | $701.7K | $1.8M | $882.7K | $3.2M | $3.2M | $3.9M | $4.0M | $4.9M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$7.1M | $28.2M | -$678.9K | -$152.8K | $226.5K | ||||||||||||
| Accrued Liabilities Current | $10.9M | $4.4M | $3.5M | $4.0M | $939.1K | $1.2M | $375.4K | $661.3K | $321.0K | $536.2K | $458.5K | $96.5K | $1.0K | ||||
| Interest Earned On Marketable Securities Held In Trust Account | $4.0M | $6.6M | $5.9M | $5.4M | $2.4M | $703.4K | $126.3K | $40.9K | |||||||||
| Unrealized Gain Loss On Investments | $52.9K | -$52.9K | $56.7K | -$126.2K | $14.6K | -$7.1K | $0.00 | ||||||||||
| Deferred Offering Costs Noncurrent | $7.0M | $7.0M | $17.5M | $17.5M | $17.5M | $17.5M | $17.5M | $17.5M | $17.5M | ||||||||
| Assets Held In Trust Noncurrent | $307.5M | $303.6M | $518.2M | $515.9M | $511.5M | $503.3M | $500.8M | $500.3M | $500.0M | ||||||||
| Deferred Legal Fees Noncurrent | $92.4K | $92.4K | $92.4K | $92.4K | $92.4K | $92.4K | $92.4K | $92.4K | |||||||||
| Property Plant And Equipment Net | $11.5M | $3.7M | $1.5M | $679.9K | $637.7K | ||||||||||||
| Prepaid Expense And Other Assets Current | $10.2M | $8.2M | $3.9M | $3.4M | $3.9M | ||||||||||||
| Operating Lease Right Of Use Asset | $1.6M | $1.8M | $1.7M | $1.1M | $37.8K | ||||||||||||
| Operating Lease Liability Current | $880.0K | $854.0K | $681.0K | $466.6K | $37.8K | ||||||||||||
| Deferred Issuance Costs Included In Accounts Payable | $0.00 | $800.0K | |||||||||||||||
| Common Stock Value | $16.0K | $15.0K | $14.0K | $12.2K | $12.2K | ||||||||||||
| Accounts Payable Current | $2.0M | $2.3M | $1.4M | $361.2K | $1.1M | ||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | $0.00 | $0.00 | $500.0M | $500.0M | $500.0M | $500.0M | |||||||||
| Other Assets Noncurrent | $5.2M | $161.0K | $157.0K | $115.0K | |||||||||||||
| Right Of First Refusal Liability | $25.0M | $25.0M | $25.0M | $25.0M | |||||||||||||
| Operating Lease Liability Noncurrent | $781.0K | $1.0M | $1.1M | $670.2K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$82.2M | -$38.4M | -$16.0M | -$954.7K | -$1.9M |
| Net Cash Provided By Used In Investing Activities | -$489.7M | -$175.8M | -$83.0K | $1.2M | -$500.0M |
| Net Cash Provided By Used In Financing Activities | $1.26B | $301.4M | $16.3M | $505.2M | |
| Payments Of Stock Issuance Costs | $2.8M | $11.1M | $3.1M | $727.8K | |
| Depreciation Depletion And Amortization | $522.0K | $268.0K | $75.0K | ||
| Increase Decrease In Accrued Liabilities | $197.4K | $21.5K | $387.7K | ||
| Increase Decrease In Prepaid Expense | $9.9K | -$835.7K | $1.3M | ||
| Increase Decrease In Accrued Income Taxes Payable | -$375.2K | $1.2M | $2.4K | ||
| Share Based Compensation | $41.8M | $12.5M | $777.0K | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $21.6M | $1.5M | $126.0K | ||
| Increase Decrease In Other Noncurrent Assets | $77.0K | $115.0K | -$26.0K | ||
| Increase Decrease In Other Accrued Liabilities | $12.3M | -$1.5M | $384.0K | ||
| Increase Decrease In Accounts Payable | -$1.5M | -$1.8M | $1.3M | ||
| Payments To Acquire Property Plant And Equipment | $33.2M | $352.0K | $83.0K | ||
| Proceeds From Stock Options Exercised | $4.0M | $1.0M | $114.0K | ||
| Proceeds From Right Of First Refusal Liability | $0.00 | $25.0M | $0.00 | ||
| Proceeds From Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes | $7.9M | $195.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q2 2023 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$12.2M | -$7.3M | -$678.9K | -$152.8K | $0.00 | |||||
| Net Cash Provided By Used In Investing Activities | $6.1M | -$97.0K | ||||||||
| Net Cash Provided By Used In Financing Activities | -$875.0K | $35.5M | $226.5K | |||||||
| Payments Of Stock Issuance Costs | $0.00 | $137.0K | $298.5K | |||||||
| Depreciation Depletion And Amortization | $124.0K | $125.0K | $124.0K | $68.0K | $63.0K | $49.0K | $12.4K | |||
| Increase Decrease In Accrued Liabilities | $412.1K | $331.8K | $163.2K | $1.0K | ||||||
| Increase Decrease In Prepaid Expense | -$149.9K | -$146.7K | -$213.1K | $0.00 | ||||||
| Increase Decrease In Accrued Income Taxes Payable | $654.1K | $1.4M | ||||||||
| Share Based Compensation | $2.3M | $667.0K | ||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$336.0K | $291.0K | ||||||||
| Increase Decrease In Other Noncurrent Assets | $17.0K | -$25.0K | ||||||||
| Increase Decrease In Other Accrued Liabilities | $1.6M | $73.0K | ||||||||
| Increase Decrease In Accounts Payable | -$1.8M | -$574.0K | ||||||||
| Payments To Acquire Property Plant And Equipment | $332.0K | $97.0K | ||||||||
| Proceeds From Stock Options Exercised | $720.0K | $440.0K | ||||||||
| Proceeds From Right Of First Refusal Liability | $0.00 | $25.0M | ||||||||
| Proceeds From Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes | $1.5M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2018 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.72 | -$0.74 | -$0.47 | |||
| Weighted Average Number Of Shares Outstanding Basic | 146.4M | 98.9M | 68.9M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 146.4M | 98.9M | 68.9M | |||
| Earnings Per Share Basic | $-0.72 | $-0.74 | $-0.47 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | ||||
| Preferred Stock Shares Authorized | 1.0M | 1.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | ||||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | |||
| Common Stock Shares Outstanding | 160.5M | 137.7M | 69.2M | |||
| Common Stock Shares Issued | 160.5M | 137.7M | 69.2M | 39.9M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |||
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 0.00 | 6.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.20 | -$0.18 | -$0.07 | -$0.08 | -$0.27 | -$0.34 | -$0.13 | -$0.06 | $0.00 | ||||||
| Weighted Average Number Of Shares Outstanding Basic | 150.4M | 140.1M | 138.1M | 122.1M | 100.0M | 70.3M | 68.5M | 68.8M | |||||||
| Weighted Average Number Of Diluted Shares Outstanding | 150.4M | 140.1M | 138.1M | 122.1M | 100.0M | 70.3M | 68.5M | 68.8M | |||||||
| Earnings Per Share Basic | $-0.20 | $-0.18 | $-0.07 | $-0.08 | $-0.27 | $-0.34 | $-0.13 | $-0.06 | |||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | ||||||||||
| Common Stock Shares Outstanding | 156.2M | 147.6M | 139.2M | 122.1M | 122.1M | ||||||||||
| Common Stock Shares Issued | 156.2M | 147.6M | 139.2M | 122.1M | 122.1M | ||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating Costs And Expenses | $4.3M | $1.8M | $1.2M | ||
| Additional Paid In Capital | $1.72B | $383.7M | $27.1M | $0.00 | $0.00 |
| Investment Income Interest | $22.2M | $7.3M | $117.7K | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $41.8M | $12.5M | $777.0K | ||
| Prepaid Expense Current | $420.8K | $840.7K | |||
| Stock Redeemed Or Called During Period Value | $14.8M | $4.5M | $26.7M | ||
| Investment Income Interest And Dividend | $29.1M | $7.7M | $180.0K | ||
| Stock Issued During Period Value New Issues | $4.0M | $1.0M | $25.0K | $25.0K | |
| Stock Issued During Period Value Stock Options Exercised | $4.0M | $1.0M | $114.0K | ||
| Financial Instruments Subject To Mandatory Redemption Settlement Terms Change In Fair Value Of Shares | 0.00 | -27.9M | -13.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Costs And Expenses | $1.0M | $2.0M | $901.5K | $1.2M | $402.6K | $430.7K | $529.1K | $569.0K | $1.0K | |||||||
| Additional Paid In Capital | $1.40B | $864.7M | $412.6M | $385.4M | $6.4M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $23.8K | |||
| Investment Income Interest | $4.0M | $5.4M | $126.3K | $0.00 | ||||||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $9.1M | $11.4M | $2.3M | $1.6M | $8.5M | $667.0K | $47.4K | $48.6K | $48.2K | |||||||
| Prepaid Expense Current | $280.9K | $430.7K | $32.3K | $42.5K | $274.2K | $652.5K | $831.7K | $835.6K | $1.5M | |||||||
| Stock Redeemed Or Called During Period Value | $1.5M | $4.4M | $4.6M | $3.2M | $1.4M | $26.7M | ||||||||||
| Investment Income Interest And Dividend | $7.1M | $3.8M | $3.7M | $2.5M | $1.7M | $141.0K | $78.8K | $137.00 | ||||||||
| Stock Issued During Period Value New Issues | $440.1M | $260.9M | $25.0K | $25.0K | ||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $1.4M | $628.0K | $720.0K | $440.0K | $38.7K | |||||||||||
| Financial Instruments Subject To Mandatory Redemption Settlement Terms Change In Fair Value Of Shares | 0.00 | 0.00 | 0.00 | 0.00 | -11.1M | -16.8M | -4.1M |
Most recent annual filing with the SEC: March 17, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.